Aromatase inhibitors for the treatment of breast cancer: An overview (2019–2023)

N Bhatia, S Thareja - Bioorganic Chemistry, 2024 - Elsevier
Aromatase inhibition is considered a legitimate approach for the treatment of ER-positive
(ER+) breast cancer as it accounts for more than 70% of breast cancer cases. Aromatase …

Aromatase Inhibitors as a Promising Direction for the Search for New Anticancer Drugs

S Janowska, S Holota, R Lesyk, M Wujec - Molecules, 2024 - mdpi.com
Aromatase is an enzyme that plays a crucial role in the biosynthesis of estrogens, which are
hormones that contribute to the growth of certain types of breast cancer. In particular …

Design and synthesis of newly synthesized acrylamide derivatives as potential chemotherapeutic agents against MCF-7 breast cancer cell line lodged on PEGylated …

I Zaki, RAI Abou-Elkhair, AH Abu Almaaty, O A. Abu Ali… - Pharmaceuticals, 2021 - mdpi.com
Cancer is a multifaceted disease. With the development of multi drug resistance, the need
for the arousal of novel targets in order to avoid these drawbacks increased. A new series of …

Novel imidazole derivatives as potential aromatase and monoamine oxidase-B inhibitors against breast cancer

D Osmaniye, S Levent, BN Sağlık… - New Journal of …, 2022 - pubs.rsc.org
In this study, we developed a series of new aromatase MAO-B dual inhibitors against breast
cancer. Aromatase inhibitors are the most commonly used drugs clinically for breast cancer …

Discovery of novel tris-1, 2, 3-triazole-based hybrids as VEGFR2 inhibitors with potent anti-proliferative and cytotoxicity through apoptosis induction

M Alsehli, AAS Ali, MS Nafie, S Bardaweel… - Bioorganic …, 2025 - Elsevier
The discovery of novel anti-cancer drugs motivated us to synthesize a new series of triple 1,
2, 3-triazole-based arm scaffolds featuring distinct un/functionalized alkyl and/or aryl side …

[HTML][HTML] (E)-1-(3-(3-Hydroxy-4-Methoxyphenyl)-1-(3,4,5-Trimethoxyphenyl)allyl)-1H-1,2,4-Triazole and Related Compounds: Their Synthesis and Biological …

G Ana, AM Malebari, S Noorani, D Fayne, NM O'Boyle… - Pharmaceuticals, 2025 - mdpi.com
Background/Objectives: The synthesis of (E)-1-(1, 3-diphenylallyl)-1 H-1, 2, 4-triazoles and
related compounds as anti-mitotic agents with activity in breast cancer was investigated …

Special Issue “Anticancer Drugs 2021”

MJ Meegan, NM O'Boyle - Pharmaceuticals, 2022 - mdpi.com
This Special Issue of Pharmaceuticals is devoted to significant advances achieved in the
field of Anticancer Drugs in 2021. Recent findings and trends in the design, synthesis and …

[HTML][HTML] SYNTHESIS, BIOCHEMICAL AND IN SILICO EXPLORATION OF NOVEL IMIDAZOLE BASED 1,2,3-TRIAZOLES AS POTENTIAL HIT AGAINST CARBONIC …

M Hussain, PA Channar, AA Alsfouk, SA Ejaz, M Aziz… - Química …, 2024 - SciELO Brasil
This study aimed to synthesize novel compounds as more effective carbonic anhydrase II
inhibitors. For this purpose, 2-(3-methoxy-4-(prop-2-yn-1-yloxy) phenyl)-4, 5-diphenyl-1H …

[PDF][PDF] A. Abu Ali, O.; Fayad, E.; Ahmed Gaafar, AGA; Zakaria, MY Design and Synthesis of Newly Synthesized Acrylamide De-rivatives as Potential Chemotherapeutic …

I Zaki, RAI Abou-Elkhair, AH Abu Almaaty - Pharmaceuticals, 2021 - academia.edu
Cancer is a multifaceted disease. With the development of multi drug resistance, the need
for the arousal of novel targets in order to avoid these drawbacks increased. A new series of …

Design and Synthesis of Imidazole Derivatives as Anticancer Agents and Potential Aromatase Inhibitors

HE BOSTANCI, UA Çevik - Cumhuriyet Science Journal, 2022 - csj.cumhuriyet.edu.tr
In this study, imidazole derivative compounds were synthesized using the Debus-
Radziszewski method. The chemical structures of the compounds were characterized by …